Michael J. Porro & Co. Financial Advisors, Inc.’s Jazz Pharmaceuticals JAZZ Stock Holding History

Michael J. Porro & Co. Financial Advisors, Inc.’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$556K	Buy	+3,273	New	+$502K	0.47%	76

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Michael J. Porro & Co. Financial Advisors, Inc.'s JAZZ Position: Q4 2025 in Review

Michael J. Porro & Co. Financial Advisors, Inc. opened a new position in Jazz Pharmaceuticals (JAZZ) in Q4 2025: 3,273 shares worth $556K. The stake represents 0.47% of the portfolio and ranks #76 among its holdings.

576 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

Michael J. Porro & Co. Financial Advisors, Inc. held 3,273 shares of Jazz Pharmaceuticals worth $556K as of Q4 2025.
Jazz Pharmaceuticals was a new Michael J. Porro & Co. Financial Advisors, Inc. position in Q4 2025.
Jazz Pharmaceuticals made up 0.47% of Michael J. Porro & Co. Financial Advisors, Inc.'s portfolio in Q4 2025, its #76 holding.
576 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on Michael J. Porro & Co. Financial Advisors, Inc.'s 13F filing for Q4 2025, filed 8 Oct 2026.